EUVIMEDEUVIMED entdecken
Crossref

Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study

Yaqian Zhou iD, Yan Wang, Zhiting Zhang, Xue Yin, Jianjun Liu iD, Wei Zheng iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Yaqian Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Health Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To study whether male sex is a risk factor for prognosis in patients with differentiated thyroid cancer after 131I treatment using the propensity score matching (PSM) method.

Methods

From April 2016 to October 2021, 1948 postoperative differentiated thyroid cancer patients aged 43 (interquartile range: 34, 54) years who received 131I treatment were retrospectively enrolled and divided into male (n = 645) and female groups (n = 1303). The PSM method was adopted to process all data to reduce the influence of data bias and confounding variables. The Mann-Whitney U test and χ2 test were used for data analysis. Multivariate logistic regression was used to analyze the risk factors affecting prognosis, and the receiver operating characteristic curve was used to analyze the relationship between stimulated thyroglobulin (sTg) level, 131I dose, and poor prognosis.

Results

Before PSM, the proportion of male patients with poor prognosis was significantly higher than that of female patients. After PSM, there was no difference in the proportion of poor prognosis between male and female groups. Multivariate logistic regression analysis showed that male sex; high T stage, N1b stage, and M1 stage; high sTg level; and high 131I dose were risk factors for poor prognosis before PSM. After PSM, high T stage, M1 stage, high sTg level, and 131I dose were still risk factors but male sex was no longer a risk factor for poor prognosis.

Conclusions

After the reduction of selection bias by PSM, male sex was no longer a risk factor for prognosis after 131I treatment of differentiated thyroid cancer. In addition, high T stage (T3 + T4 stage), M1 stage, sTg ≥10.15 ng/mL, and 131I dose ≥260 mCi were risk factors for poor prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinomaHumansMaleFemaleIodine RadioisotopesRetrospective StudiesPropensity ScoreThyroglobulinPrognosisRisk Factors

Stichwörter der Autor:innen

131I treatmentdifferentiated thyroid cancerprognosispropensity score matchingrisk factorssex

Substanzen

Iodine-131Iodine RadioisotopesThyroglobulin

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300041, China.
  • Department of Nuclear Medicine, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China.

ORCID-Profile: Yaqian Zhou, Jianjun Liu, Wei Zheng

Förderung

  • Health Science and Technology

Zitieren

APA

Zhou, Y., Wang, Y., Zhang, Z., Yin, X., Liu, J., & Zheng, W. (2023). Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad314

Vancouver

Zhou Y, Wang Y, Zhang Z, Yin X, Liu J, Zheng W. Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad314

BibTeX
@article{Zhou2023,
  author = {Zhou, Yaqian and Wang, Yan and Zhang, Zhiting and Yin, Xue and Liu, Jianjun and Zheng, Wei},
  title = {Male Sex Is Not a Risk Factor for Prognosis in Postoperative Thyroid Cancer Patients: A Propensity Score Matching Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad314}
}
Kostenlos starten →